Literature DB >> 2433282

Effects of viral chemotherapeutic agents on membrane properties. Studies of cyclosporin A, benzyloxycarbonyl-D-Phe-L-Phe-Gly and amantadine.

R M Epand, R F Epand, R C McKenzie.   

Abstract

Cyclosporin A, benzyloxycarbonyl-D-Phe-L-Phe-Gly, and amantadine inhibit the dilution of fluorescently labeled lipids, as measured with the resonance energy exchange assay for membrane fusion. The fusion was studied using sonicated vesicles containing 1,2-dioleoyl-sn-glycero(3)phosphoethanolamine, egg (3-sn-phosphatidyl)choline, and cholesterol in a 1:1:1.3 molar ratio. All three antiviral agents inhibited myelin basic protein-induced membrane fusion when present at low concentrations in the membrane. The mechanism by which these agents affect membrane properties was investigated. The effect of these agents on the bilayer to hexagonal phase transition of 1,2-dielaidoyl-sn-glycero(3)phosphoethanolamine was determined using both differential scanning calorimetry and 31P NMR. Benzyloxycarbonyl-D-Phe-L-Phe-Gly is particularly effective in raising the bilayer to hexagonal phase transition temperature while cyclosporin promotes the greatest amount of broadening of the 31P NMR signal. Both effects are suggested to be related to the inhibitory activity of these substances on membrane fusion and possibly also to their antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433282

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Solid-state NMR and MD simulations of the antiviral drug amantadine solubilized in DMPC bilayers.

Authors:  Conggang Li; Myunggi Yi; Jun Hu; Huan-Xiang Zhou; Timothy A Cross
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

2.  An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition.

Authors:  Yuki Ohigashi; Chunlong Ma; Xianghong Jing; Victoria Balannick; Lawrence H Pinto; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

3.  Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.

Authors:  C Wang; K Takeuchi; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

Review 4.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

5.  Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.

Authors:  B J Owens; G M Anantharamaiah; J B Kahlon; R V Srinivas; R W Compans; J P Segrest
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Evaluation of the antiviral effect of synthetic oligopeptides whose sequences are derived from paramyxovirus F1 N termini.

Authors:  N M Inocencio; B Gotoh; T Toyoda; C Kitada; Y Nagai
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

7.  Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.

Authors:  Xianghong Jing; Chunlong Ma; Yuki Ohigashi; Fernando A Oliveira; Theodore S Jardetzky; Lawrence H Pinto; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

8.  Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes.

Authors:  Udayan Chatterji; Michael D Bobardt; Precious Lim; Philippe A Gallay
Journal:  J Gen Virol       Date:  2010-01-27       Impact factor: 3.891

9.  A comparison of membrane properties and composition between cell lines selected and transfected for multi-drug resistance.

Authors:  R Callaghan; L C van Gorkom; R M Epand
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.